St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients' Heart Structures
INDIANAPOLIS, July 8 /PRNewswire/ -- A surgeon at the St. Francis Heart Center is using a revolutionary technology that allows patients to rebuild their own cardiovascular tissue.
(Logo: http://www.newscom.com/cgi-bin/prnh/20090708/DE43062LOGO-a )
Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies
SAN MARINO, Calif., Nov. 20 /PRNewswire/ -- Epeius Biotechnologies
announced today the results of Phase I/II and II studies of Rexin-G in
chemotherapy-resistant metastatic soft tissue
sarcoma and osteosarcoma, as
presented by Dr. Sant P. Chawla, principal investigator, at the CTOS 14th
Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
Potential for data analysis early 2009
SEATTLE, Aug. 12 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.'s
(CTI) (Nasdaq: CTIC ; MTA) subsidiary Systems Medicine (SM) announced today
that planned enrollment is complete in the European Organization for
Research and Treatment ...
FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
Pathwork Diagnostics' Gene Expression Test Is the First to Receive FDA
Clearance for Diagnosis of Uncertain Tumors; Problem Affects 200,000 New U.S. Cancer Cases Annually
SUNNYVALE, Calif., July 31 /PRNewswire/ -- Pathwork Diagnostics, Inc.,
a molecular diagnostics com...
Children's Brain Tumor Foundation's Tissue Bank Consortium May Solve Dire Problem in Pediatric Cancer Research
Leading Institutions in Philadelphia, Pittsburgh and Chicago To Launch
NEW YORK, July 1 /PRNewswire-USNewswire/ -- In a major effort to speed
treatment and cures for pediatric brain tumors and cancer, the Children's
Brain Tumor Foundation (CBTF) today launched the in...
Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
SAN MARINO, Calif., May 29 /PRNewswire/ -- Epeius Biotechnologies
( http://www.epeiusbiotech.com ) announced today the results of an on-going
Phase I/II study of Rexin-G for metastatic bone and soft tissue
Clin Oncol 26: 14509, 2008). Rexin-G is the first and so far only targeted
Cardium and Tissue Repair Company's Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
SAN DIEGO, March 17 /PRNewswire-FirstCall/ -- Cardium Therapeutics
(Amex: CXM ) and its subsidiary, Tissue
Repair Company (TRC) today reported
that the Phase 2b MATRIX clinical study has been the focus of media
attention in multiple regions across the U.S., including television news
Study Finds Starion Instruments' Tissue Welding Technology Safe and Effective in Parotidectomy Procedures
Technology minimizes risk of postoperative facial paresis
SUNNYVALE, Calif., March 4 /PRNewswire/ -- Starion Instruments, a
leading surgical device company, today announced that a study published in
the January 2008 issue of The American Surgeon found Starion's patented
Tissue Welding t...
Study of Pathwork Diagnostics' Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
SUNNYVALE, Calif., Dec. 14 /PRNewswire/ -- Pathwork Diagnostics, a
genomics-based diagnostics company focused on oncology, announced that its
of Origin Test is the focus of a study published in the
January issue of The Journal of Molecular Diagnostics. Pathwork's
Raydiance Collaborates With Rutgers University and Nation's Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
Scientists Leveraging Precision and Power of Raydiance USP Laser Platform
to Separate Skin Layers Without Collateral Damage; Decontaminate Tissue; Speed Tissue
Initial Proof of Concept Testing Successful During Feasibility Trials
PETALUMA, Calif. and NEW BR...
Study Finds Starion Instruments' Tissue Welding Technology Reduces Pain and Bleeding in Tonsillectomy Patients
Technology may improve quality of recovery compared with cold dissection procedure
SUNNYVALE, Calif., Nov. 6 /PRNewswire/ -- Starion Instruments, a
leading surgical device company, today announced that a study published in
the Annals of Otology, Rhinology & Laryng...
BioMosaics' Glypican-3 Blood & Tissue Tests Receive CE Marking in Europe
BURLINGTON, Vt., Sept. 10 /PRNewswire/ -- BioMosaics Inc., a cancer
biomarker development company, announced today that it has received CE
marking for its proprietary products for the identification of Glypican-3
(GPC3) in human blood and in tissue
as in vitro diagnostic tests. This will
National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
MOUNTAINSIDE, N.J., Aug. 14 /PRNewswire-FirstCall/ -- National Stem
Cell Holding, Inc. (OTC: NHGI.PK), today announced that Michael Cohen, CEO
of the Company, and Jacob Cohen, have discovered biomaterial derived from
non- embryonic stem cells, which appears to promote tissue
Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
Could Be Life-Changing for Stroke, Traumatic Brain Injury, Alzheimer's Patients
MORGANTOWN, W.Va., Sept. 1 /PRNewswire-USNewswire/ -- Scientists at the
Blanchette Rockefeller Neurosciences Institute (BRNI) have discovered that
Bryostatin -- and a related class o...
Knee Pain? An Exclusive Study Engineers Cartilage to Match Patient's Own Tissue
MINNEAPOLIS, Jan. 8 /PRNewswire/ -- Patients with knee cartilage
injuries now have the opportunity to re-grow their cartilage as part of an
innovative study at TRIA Orthopaedic Center, in Bloomington, MN. Cartilage
is the tough but flexible tissue
that covers the ends of your bones at a
CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
KIRKLAND, Wash., Sept. 11 /PRNewswire-FirstCall/ -- CellCyte Genetics
Corporation (the "Company") (OTC Bulletin Board: CCYG) has entered into a
collaborative research agreement with physician scientists at the Cleveland
Clinic Foundation of Cleveland, Ohio. The goal of the collaboration is to
BioLineRx Presents Data on BL-1040 at Cardiovascular
Revascularization Therapies Conference Demonstrating Potential to
Reduce Deterioration of Infarcted Heart Tissue and Maintain
JERUSALEM--(BUSINESS WIRE)--Mar 7, 2007 - BioLineRx Ltd.
(TASE:BLRX), Israel's leading drug development company, reported
today pre-clinical data from trials of BL-1040 demonstrating that
BL-1040 is effective in preventing deterioration of the myocardium
after a myocardial infarction (MI), thereby ...
Novel Human Tissue Transgenic Cancer Model May Offer Significant
Advance Toward Accurately Modeling Human Cancer
LOS ANGELES & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 18, 2007 -
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on
the discovery and development of novel, targeted cancer medicines,
presented today findings from its novel human-in-mouse (HIM) tissue
transgenic cancer model syste...
GSK'S Pazopanib Shows Positive Results in Patients with Advanced
Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma
CHICAGO, June 04, 2007 /PRNewswire/ -- GlaxoSmithKline today
announced results from ongoing Phase II studies of pazopanib in
advanced or metastatic renal cell carcinoma (RCC), ovarian cancer
and soft tissue
sarcoma (STS). These trials were presented at the
43rd Annual Meeting of the American Socie...
Fat Kills Cancer: Turning Stem Cells from Fat Tissue into
Personalized, Cancer-Targeted Therapeutics
PHILADELPHIA, July 3, 2007 ? Researchers in Slovakia have
been able to derive mesenchymal stem cells from human adipose, or
and engineer them into “suicide genes” that
seek out and destroy tumors like tiny homing missiles.
This gene therapy approach is a novel way to atta...
Schepens Scientists Identify Key to Integrating Transplanted Nerve
Cells Into Injured Tissue
Discovery promises to make retina, spinal cord and other central
nervous system transplants possible
BOSTON, April 26, 2007 /PRNewswire/ -- Scientists at the
Schepens Eye Research Institute, an affiliate of Harvard Medical
School, have identified a key mechanism for successfully
Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009
Eli Lilly and Company recently completed its Phase 1 study of LY2181308 and presented data confirming that LY2181308 penetrates tumor tissue
and reduces survivin mRNA and protein levels in tumor cells.
Isis and its collaborators highlighted new antisense therapeutic pr...
Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors
...uter-controlled delivery system is used to optimize the dose distribution to the target. As a result of this precise delivery, the surrounding healthy tissue
and critical organs are preferentially spared from high doses of radiation and side effects may be reduced.
Unlike low dose rate brachytherapy ...
Radius' Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
...dy's co-primary endpoints were change from baseline in lumbar spine BMD and changes in anabolic bone markers. BMD is a measurement of mineralized bone tissue
used to diagnose osteoporosis and to help determine a patient's fracture risk, as well as response to treatment.
About PTHrP and PTH
Scientists Discover Origin of Malaria
...r abandoned by human owners. In Ivory Coast scientists from the Robert Koch Institute and Max Planck Institute for Evolutionary Anthropology collected tissue
and blood samples from 10 chimps that had died due to anthrax, respiratory disease or other reasons in the Tai National Park. Samples were analyzed in...
Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
...ses in prostate cancer.
Bone Metastases: Impact and Prevalence
Bone metastases, cancer cells that separate from tumors and migrate to bone tissue
where they settle and grow, occur in more than 1.5 million people worldwide.(1) With improvements in cancer care, including earlier diagnosis and new ...
Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window
...ued Nogueira, when brain imaging studies revealed that a significant number of late-presenting stroke patients showed evidence of salvageable brain tissue
in the area of the stroke, it was an important avenue to pursue. This meant that endovascular therapy (performed by neurointerventional specialists w...
VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
... the Massachusetts General Hospital's Center for Systems Biology found that monocytes were held in concentration in the spleen and released to injured tissue
sites in the body to participate in wound healing. As presented in the findings, the reporting scientists discovered and detailed the biologic pathwa...
Montefiore Medical Center and Albert Einstein College of Medicine Herald New Agreement To Continue Forty-Plus Year Historic Relationship
... programs at the North Division.
Distinguished centers of excellence at Montefiore include cardiology and cardiac surgery , cancer care , tissue
and organ transplantation, children's health , women's health , surgery and the surgical subspecialties . Montefiore is a national leader in...
Wyeth Reports Publication of Phase 3 Data for Bazedoxifene/Conjugated Estrogens, an Investigational Compound Being Studied for the Treatment of Menopausal Symptoms
Titles and Summary of Findings From Published Manuscripts
1. Endometrial Protection in Menopausal Therapy with a tissue
Selective Estrogen Complex (TSEC) Containing Bazedoxifene/Conjugated Estrogens (Pickar JH, et al)
To evaluate endometrial effects, biopsies w...
Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.
...rus grows outside of the uterus, resulting in scar tissue
that causes severe pelvic pain and may lead to inf...Cryopraxis is primarily dedicated to stem cell and tissue
banking. Cryopraxis is a leader in stem cell, bone...te-of-the-art Good Manufacturing Practice and Good tissue
Practice (cGMP/cGTP)-compliant facility. Cryo-Cell...
World's First Cardiac Adult Stem Cell Patient Receives Infusion
...ed with his own cardiac stem cells into heart scar tissue
using a minimally-invasive cardiac catheterization...is own atrium, the upper chamber of the heart. The tissue
was then sent to Piero Anversa, of Harvard Univers...rial. We hope to help the heart regenerate its own tissue
and improve heart function." Bolli is collaboratin...
First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center
...ivers a high therapeutic dose to a cancer tumor while sparing nearby normal tissue
by using a miniaturized X-ray source rather than radioactive isotopes.
...o the region at risk with minimal radiation exposure to surrounding healthy tissue
and without the complex handling, resource logistics and costs associated w...
Injection Reverses Heart-Attack Damage
BOSTON, July 23 /PRNewswire-USNewswire/ -- Injured heart tissue
normally can't regrow, but researchers at Children's Hospital Boston have now laid the groundwork for regenerating heart tissue
after a heart attack, in patients with heart failure, or in children with c...
National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness
...antly hematologic toxicities. Activity was demonstrated in a number of solid tumor types. A phase II study of brostallicin in relapsed/refractory soft tissue
sarcoma met its pre-defined activity and safety hurdles and resulted in a first-line phase II study that is currently being conducted by the European ...
First Potential Lupus-Specific Treatment in Sight
Lupus is an acute and chronic autoimmune disease in which the immune system is unbalanced, causing inflammation and tissue
damage to virtually any organ in the body. Its health effects include heart attacks, strokes, seizures, miscarriages, and organ failure. Ninety percen...
Bionovo's Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity
...f their drugs to safely and effectively treat menopausal symptoms.
"It is essential that new drug candidates demonstrate drug selectivity and tissue
specificity in order to minimize adverse effects, particularly when the drug is being developed for the treatment of common, recurring symptoms associ...
Elbit Imaging Ltd. Announces - Swiss Team Uses InSightec's ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders
...utcome in real time - and high intensity
focused ultrasound to target brain tissue
non-invasively. MR thermometry
allows the physician to control and adjust t...real time to
ensure that the targeted area is fully treated and surrounding tissue
spared. The ExAblate 4000 is a platform for a variety of transcranial
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
... HPV DNA using the HC2 test, the most widely used clinical HPV test, and 77 tissue
samples taken from tumors in confirmed cervical cancer patients were analyz...of the 15 HPV genotypes in liquid cytology samples from cervical smears and tissue
biopsy samples. The AttoSense test is currently available for Research Use...
Risks of Delaying ACL Reconstruction in Young Athletes May Be Too High, Study Shows
...the decision was made to delay treatment, patients were instructed to wear a custom ACL brace. All patients who underwent the surgery utilized a soft tissue
graft with anatomically placed tunnels and fixation devices that did not cross the growth plate. Patients were also followed for a minimum of one-year...